**Core Concept:** Vi polysaccharide vaccine is a type of immunotherapy used to protect against Salmonella typhi, the bacteria responsible for causing typhoid fever. This vaccine is composed of Vi polysaccharide, a capsular polysaccharide antigen from the bacterial cell wall. The vaccine is intended for adults and adolescents, not suitable for children below 5 years old.

**Why the Correct Answer is Right:** Vi polysaccharide vaccine is administered intramuscularly (IM) into the deltoid muscle, as it is an effective way to stimulate the immune system to produce antibodies against the Vi polysaccharide antigen. Intramuscular administration allows for rapid absorption of the vaccine and facilitates the distribution of the antigen throughout the body, where it can be recognized by the immune system and lead to an immune response.

**Why Each Wrong Option is Incorrect:**

A. **Subcutaneous (SC) administration:** This option is incorrect because Vi polysaccharide vaccine is not absorbed efficiently from the subcutaneous tissue, leading to suboptimal immune response.

B. **Oral administration:** Typhoid fever is caused by Salmonella typhi, a gram-negative bacterium that typically enters the body through the gastrointestinal tract and then disseminates systemically, which is not the case for Vi polysaccharide vaccine administration. Oral administration of the vaccine would be ineffective in generating an immune response against the causative organism.

C. **Intravenous administration:** This option is incorrect because Vi polysaccharide vaccine is not formulated to be administered intravenously. Intramuscular injection is the appropriate route due to the vaccine's specific formulation and the body's response to the antigen when injected into the muscle tissue.

D. **Subcutaneous administration (SC):** This option is incorrect as mentioned above, Vi polysaccharide vaccine is not absorbed efficiently from the subcutaneous tissue, resulting in suboptimal immune response.

**Clinical Pearls:**

- Intramuscular administration is crucial for generating an effective immune response with Vi polysaccharide vaccine, ensuring that the antigen is delivered to the appropriate site for immune system recognition and response.
- Vi polysaccharide vaccine is specifically formulated for intramuscular administration, as it targets the immune system's ability to produce antibodies against the Vi polysaccharide antigen.

**Correct Answer Explanation:** Intramuscular administration (option C) allows for the vaccine to be taken up by antigen-presenting cells in the muscle tissue and transported to the lymph nodes and then to the spleen and lymph nodes, where it is processed and presented to T cells, leading to B cell activation and antibody production against the Vi polysaccharide antigen. This ensures a robust immune response against Salmonella typhi and protection against typhoid fever.